A protein to protect against Parkinson’s

PRX-105 from Israel’s Protalix Biotherapeutics may help drive the brain’s transcription machinery to follow a protective path leading to new treatment options for Parkinson’s disease.
http://www.globes.co.il/serveen/globes/docview.asp?did=1000696842&fid=1725

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *